Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell

CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell

US Patent 11149076 · Granted Oct 19, 2021

Estimated economic value: $44,668,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-TCR antibody molecules and uses thereof2025
Mobile phone2025
Chimeric antigen receptor T regulatory cells for the treatment of atherosclerosi2025
Signal communication based on levitated particle2025
To-be-executed instruction prediction method and system2025
Device and method for detecting internal defect of battery cell by using tdr2025
Implementing a policy-based agent with plugin infrastructure2025
Multispecific antibody molecules comprising lambda and kappa light chains2025
Physical uplink control channel transmission method and apparatus, device and me2025
Downlink data receiving method, downlink data sending method, and device2025
Stateful order-preserving encryption method and apparatus for enhancing security2025
Apparatus and method for validating data2025